Novel Buprenorphine Combination Therapy Shows Efficacy for MDD in Long-Term Trial - Psychiatry Advisor

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Novel Buprenorphine Combination Therapy Shows Efficacy for MDD in Long-Term Trial  Psychiatry AdvisorNEW YORK — ALKS 5461, a novel treatment approach in major depressive disorder (MDD) consisting of a combination of buprenorphine (a μ-opioid receptor ...